Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 12, Issue 1
Management of infliximab refractory immune checkpoint inhibitor gastrointestinal toxicity: a multicenter case series
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
PDF +
Supplementary
Material
Clinical/translational cancer immunotherapy
Original research
Management of infliximab refractory immune checkpoint inhibitor gastrointestinal toxicity: a multicenter case series
Online download statistics by month:
Online download statistics by month: January 2024 to October 2025
Abstract
Full
Pdf
Jan 2024
90
91
21
Feb 2024
450
452
225
Mar 2024
228
230
121
Apr 2024
185
187
65
May 2024
208
212
74
Jun 2024
208
211
69
Jul 2024
180
180
57
Aug 2024
191
189
62
Sep 2024
161
161
48
Oct 2024
199
201
60
Nov 2024
288
289
60
Dec 2024
338
343
51
Jan 2025
268
269
67
Feb 2025
387
390
64
Mar 2025
267
268
63
Apr 2025
283
283
82
May 2025
230
231
56
Jun 2025
158
157
43
Jul 2025
1
1
0
Oct 2025
5
5
0
Total
4325
4350
1288
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?